Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

West Pharmaceutical Services’ (WST) Robust Earnings Growth Make it a Buy

By Portfolio Grader
Portfolio Grader currently ranks West Pharmaceutical Services Inc (NYSE:WST) a Buy. With proprietary fundamental and quantitative analytical tools developed by Louis Navellier, this analytical tool researches nearly 5,000 stocks weekly. The current Portfolio Grader recommendation on the shares has been in place for 2 months.

Stellar Metrics for Earnings Growth Keep Steris (STE) a Strong Buy

By Portfolio Grader
Portfolio Grader currently ranks Steris Plc (NYSE:STE) a Strong Buy. The methodology for investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking STE has had from Portfolio Grader for the last month.

Industry Group Rank Analytics Power Abiomed (ABMD) to Strong Buy

By Portfolio Grader
As one of the 785 companies in the GICS Health Care sector Abiomed Inc (NASDAQ:ABMD) is a constituent of the 164 company Health Care Equipment & Supplies GICS industry group within this sector. ABMD has a market value of $8.6 billion which is in the top quarter of its industry group. The stock's current Portfolio Grader score places it 1 among the 164 companies in this industry group, positioning it among the leaders; in the top decile of the sector with a ranking of 1 among the 785 companies in the sector, and number 5 in the nearly 5,000 company Portfolio Grader universe.

Snap Inc (SNAP) Stock Plummets After Third-Quarter Results

By Karl Utermohlen, InvestorPlace Writer
Snap (SNAP) unveiled its third-quarter results, which came in at a loss of more than $400 million, sending shares sinking more than 16%.

Earnings Momentum Make Varian Medical Systems (VAR) a Buy

By Portfolio Grader
Varian Medical Systems Inc (NYSE:VAR) is classified as a constituent of the 164 company Health Care Equipment & Supplies GICS industry group, which is part of the 785 company GICS Health Care sector. The market value of VAR is $9.7 billion which places it in the top 25% of its industry group. The ranking for VAR by Portfolio Grader places it 45 among the 164 companies in this industry group, giving it an above-average position; in the top quartile of the sector with a ranking of 147 among the 785 companies in the sector, and number 903 in the nearly 5,000 company Portfolio Grader universe.

Anemic Quant Score Hamper Hologic (HOLX) Rating

By Portfolio Grader
Hologic Inc (NASDAQ:HOLX) is one of the 785 companies in the GICS Health Care sector, and a component of the 164 company Health Care Equipment & Supplies GICS industry group within this sector. HOLX has a market value of $11.1 billion which is in the top 25% of its industry group. The ranking for HOLX by Portfolio Grader places it 83 among the 164 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 394 among the 785 companies in the sector, and number 2,557 in the nearly 5,000 company Portfolio Grader universe.

Match Group Inc (MTCH) Average PMC Grows 18% in Third Quarter

By Karl Utermohlen, InvestorPlace Writer
Match Group (MTCH) unveiled its latest quarterly earnings results after hours and its paid member count (PMC) rose by an average of 18%.

Cooper Companies’ (COO) Robust Earnings Growth Keep it a Buy

By Portfolio Grader
Cooper Companies Inc (NYSE:COO) is ranked as a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. COO has recently seen its Portfolio Grader rating downgraded over the last month from a Strong Buy to a Buy.

Marriott International Inc (MAR) Revenue Gained 43.7% Year-Over-Year

By Karl Utermohlen, InvestorPlace Writer
Marriott International (MAR) posted revenue that surged 43.7% compared to the year-ago mark, while earnings were also higher year-over-year.

Quant Score Metrics Power Teleflex (TFX) to Strong Buy

By Portfolio Grader
Teleflex Inc (NYSE:TFX) is one of the 785 companies in the GICS Health Care sector, and a member of the 164 company Health Care Equipment & Supplies GICS industry group within this sector. TFX has a market value of $11.6 billion which is in the top quarter of its industry group. The stock's current Portfolio Grader score places it 8 among the 164 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 21 among the 785 companies in the sector, and number 169 in the nearly 5,000 company Portfolio Grader universe.

ResMed (RMD) Ranking Raised to Buy on Robust Quant Score

By Portfolio Grader
Currently, ResMed Inc (NYSE:RMD) has a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Zynga Inc (ZNGA) Earnings in Line with Estimates, Shares Tumble

By Karl Utermohlen, InvestorPlace Writer
Zynga (ZNGA) reported on its third quarter of fiscal 2017 Tuesday, yielding mixed results that sent company shares sliding after the bell.

Quant Score Make IDEXX Laboratories (IDXX) a Buy

By Portfolio Grader
The current recommendation of Buy for IDEXX Laboratories Inc (NASDAQ:IDXX) has been derived by using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking IDXX has had from Portfolio Grader for 3 months.

Dentsply Sirona (XRAY) a Sell on Falling Industry Group Rank

By Portfolio Grader
Portfolio Grader currently ranks Dentsply Sirona Inc (NASDAQ:XRAY) a Sell. The methodology for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking XRAY has had from Portfolio Grader for 2 months.

Zillow Group, Inc. (ZG) Tops Earnings, Revenue Projections

By Karl Utermohlen, InvestorPlace Writer
Zillow Group (Z) posted its quarterly earnings results after hours Tuesday, topping Wall Street's projections in earnings and revenue.

Smith & Nephew (SNN) a Strong Buy on Outstanding Earnings Visibility

By Portfolio Grader
Smith & Nephew Plc (NYSE:SNN) is a $16.4 billion in market value constituent of the Health Care Equipment & Supplies GICS industry group where the stock's current Portfolio Grader score places it 15 among the 164 companies in this industry group, putting it in the top decile. SNN is ranked among the sector leaders with a ranking of 36 among the 785 companies in the sector and number 245 in the 5000 company Portfolio Grader company universe.

Align Technology (ALGN) a Strong Buy on Exceptional Sales Growth

By Portfolio Grader
Portfolio Grader currently ranks Align Technology Inc (NASDAQ:ALGN) a Strong Buy. With exclusive fundamental and quantitative metrics developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. The current Portfolio Grader recommendation on the shares has been in place for 7 months.

Industry Group Rank Metrics Limit Edwards Lifesciences (EW) Ratings Upgrade to Hold

By Portfolio Grader
With a $21.7 billion market value, Edwards Lifesciences (NYSE:EW) ranks in the top 10% of its industry group, Health Care Equipment & Supplies, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the ranking for EW by Portfolio Grader places it 76 among the 164 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 366 among the 785 companies in the sector, and number 2,386 in the nearly 5,000 company Portfolio Grader universe.

Zimmer Biomet Holdings, Inc.’s (ZBH) Upgraded to Hold

By Portfolio Grader
The current recommendation of Hold for Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has been derived by using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. ZBH has been upgraded from a Sell to a Hold in the last week.
Load More Articles